insights_auto
Why is CSBR down 2,72%?
Dive Deeperchevron_right
CSBR:NASDAQ
Champions Oncology Inc
US$4,65
arrow_downward
-2,72%(-0,13) 1D
12 ພ.ຈ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$4,64
High
US$4,70
Low
US$4,60
Mkt. cap
64,72 ລ້ານ
Avg. vol.
8,11 ພັນ
Volume
3,99 ພັນ
52-wk high
US$8,31
52-wk low
US$4,59
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
Open
US$4,64
High
US$4,70
Low
US$4,60
Mkt. cap
64,72 ລ້ານ
Avg. vol.
8,11 ພັນ
Volume
3,99 ພັນ
52-wk high
US$8,31
52-wk low
US$4,59
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
News stories
From web sources and news partners
Eurasia Business News
·
3 ຊົ່ວໂມງກ່ອນ
Stock Market Today, November 12, 2026: Dow, S&P 500 and Nasdaq Fall After Jensen Huang Resigns
Investing.com
·
5 ຊົ່ວໂມງກ່ອນ
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.36%
ChartMill
·
7 ຊົ່ວໂມງກ່ອນ
Most Active S&P 500 Stocks: KDP, Ford, AT&T Lead Today's Session
Traders Union
·
4 ຊົ່ວໂມງກ່ອນ
Jake Wujastyk: S&P 500 and ES_F trade within last Thursday's range for a full week
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ນິວເຈີຊີ, ສະຫະລັດ
SectorHealth Care
Industry-
Websitechampionsoncology.com